PIGHI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 489
EU - Europa 319
AS - Asia 75
AF - Africa 14
SA - Sud America 2
Totale 899
Nazione #
US - Stati Uniti d'America 488
IT - Italia 208
IN - India 40
SE - Svezia 26
SG - Singapore 21
NL - Olanda 16
DE - Germania 15
CN - Cina 12
FR - Francia 12
TG - Togo 11
FI - Finlandia 9
AT - Austria 8
UA - Ucraina 6
BG - Bulgaria 4
HR - Croazia 4
GB - Regno Unito 3
AR - Argentina 2
BE - Belgio 2
IE - Irlanda 2
RO - Romania 2
CA - Canada 1
DK - Danimarca 1
ES - Italia 1
NG - Nigeria 1
SC - Seychelles 1
TR - Turchia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 899
Città #
Rome 129
Chandler 67
Fairfield 63
Ashburn 49
Houston 30
Cambridge 29
Woodbridge 27
Seattle 24
Wilmington 23
Princeton 15
San Paolo di Civitate 12
Ann Arbor 11
Dearborn 11
Lomé 11
Millbury 11
Beijing 10
Paris 10
Fasano 9
Lawrence 8
Plano 8
Pune 7
Boston 6
Cagliari 6
Singapore 6
New York 5
Vienna 5
Helsinki 4
Sofia 4
Zagreb 4
Amsterdam 3
Andover 3
Camerino 3
Naples 3
Norwalk 3
Phoenix 3
San Diego 3
Ariccia 2
Boulder 2
Brussels 2
Carmagnola 2
Ceglie Messapica 2
Dublin 2
Federal 2
Leiden 2
Livorno 2
Milan 2
Monte San Giovanni Campano 2
Napoli 2
Washington 2
Ardea 1
Babraham 1
Basildon 1
Bremen 1
Bühl 1
Casoria 1
Castel Gandolfo 1
Copenhagen 1
Davis 1
Den Helder 1
Guangzhou 1
Hanoi 1
Jacksonville 1
Kosekoy 1
Leawood 1
Leverano 1
Los Angeles 1
Madrid 1
Muizenberg 1
Nanchang 1
Reggio Calabria 1
Rotterdam 1
San Mateo 1
Santi Cosma E Damiano 1
Taranto 1
Toronto 1
Vigevano 1
Totale 678
Nome #
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production 108
(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition 94
CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis 92
Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming 91
Fine tuning of the DNAM-1/TIGIT/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD) 87
Memory NK cell features exploitable in anticancer immunotherapy 86
Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells 71
A sustained CD16 aggregation induced by therapeutic antibody-opsonised targets impairs cytotoxic responses in human NK cells 68
Impact of anti-CD20 tumor-targeting therapeutic monoclonal antibodies on human Natural Killer cell responsiveness and plasticity: relevance of FcgammaRIIIA/CD16 affinity ligation conditions 63
Harnessing cd16-mediated nk cell functions to enhance therapeutic efficacy of tumor-targeting mabs 58
null 44
The interplay between anti-CD20 therapeutic antibodies and "memory" Natural Killer cells 38
CD16 aggregation induced by therapeutic antibody-opsonised targets impairs cytotoxic responses in human NK cells 32
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition 17
Totale 949
Categoria #
all - tutte 2.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.405


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020158 14 2 4 11 17 23 19 16 16 25 8 3
2020/2021116 3 4 0 2 5 6 11 7 10 29 5 34
2021/2022177 0 5 40 4 15 6 5 18 15 14 25 30
2022/2023251 36 63 32 18 18 19 3 20 13 5 20 4
2023/2024120 9 15 5 6 16 26 9 9 0 17 7 1
Totale 949